"Revivicor, Inc. - Product Pipeline Analysis, 2013 Update" Now Available at Fast Market Research
Revivicor, Inc. (Revivicor) is a regenerative medicine company. The company uses animal biotechnology platforms to provide alternative tissue source for treatment of human degenerative disease. Its technologies include xenotransplantation, islet transplantation, and infectious disease technology. Revivicor provides genetically engineered pigs to provide human compatible cells to treat diabetes, and organs and tissues for use in transplant surgery. The company's infectious disease technology platform produces therapeutic fully human polyclonal antibodies for the treatment of various infectious diseases. It also uses gene...
View full press release